ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

NASH is the Leading Indication for Liver Transplantation in Elderly Patients

J. A. Steggerda1, J. Yang2, V. Sundaaram2, N. Alkouri3, W. Ayoub2, I. K. Kim1, M. Noureddin2

1Surgery, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, 2Hepatology, Cedars-Sinai Medical Center, Los Angeles, Los Angeles, CA, 3Gastroenterology, University of Texas Health- San Antonio, San Antonio, TX

Meeting: 2020 American Transplant Congress

Abstract number: A-174

Keywords: Elderly patients, Graft survival, Obesity

Session Information

Session Name: Poster Session A: Liver: Recipient Selection

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: Non-alcoholic steatohepatitis (NASH) is an increasingly prevalent cause of end-stage liver disease (ESLD) and indication for liver transplantation (LT) in the United States and around the world.

*Methods: United Network for Organ Sharing (UNOS) databases for waitlisted and transplanted patients were evaluated between 2006 and 2018. Pediatric patients (<18 years old) were excluded. Elderly recipients defined as ≥65 years old. Chi-square and Wilcoxon rank-sum analyses were used to compare groups. Logistic regression analyses were performed to assess likelihood of transplantation with odds ratios (OR) and 95% confidence intervals (CI) reported. Three-year graft survival was assessed with Kaplan-Meier (KM) survival analysis. P-values <0.05 were considered significant.

*Results: 129,839 patients were waitlisted for LT during the study period, of which 22,897 (14.9%) had NASH as primary diagnosis. Patients waitlisted with NASH were the oldest (median 60 years, IQR 54-65 years, p<0.0001), and predominantly male (n=12,091, 50.7%). NASH became the most common primary diagnosis amongst candidates >63 years old, at which point it accounted for 25.6% of waitlisted patients. Interestingly, NASH was the most common primary diagnosis amongst waitlisted women >59 years old, while in in men it did not become the most common until >69 years old. The median age at transplant for candidates with NASH was 64 years (IQR 59-67 years). NASH became the most common diagnosis amongst transplanted recipients >62 years old (>59 years old in women and >68 years old in men). Multivariable analysis showed that patients with NASH were more likely to be transplanted than those with HCV (OR 1.13, 95% CI 1.09-1.18, p<0.001) and ALD (OR 1.06, 1.01-1.11, p<0.001). Amongst elderly recipients, patients with NASH were more likely to be transplanted than those with HCV (OR 1.13, 1.07-1.18, p<0.001), but there was no difference between NASH and ALD (OR 1.03, 0.99-1.09, p=0.15). KM survival analyses showed no difference in 3-year graft survival across etiologies of ESLD overall, or amongst elderly recipients alone (see Figure).

*Conclusions: NASH is the most common indication for waitlisting and transplantation in elderly patients. Despite being a disease of the elderly, there is no difference in graft survival amongst recipients with NASH.

 border=

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Steggerda JA, Yang J, Sundaaram V, Alkouri N, Ayoub W, Kim IK, Noureddin M. NASH is the Leading Indication for Liver Transplantation in Elderly Patients [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/nash-is-the-leading-indication-for-liver-transplantation-in-elderly-patients/. Accessed June 6, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences